SureTrader SureTrader
Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3, GOLD DIGGAA, ILuvblo2, FreezeThese
Search This Board:
Last Post: 1/16/2017 2:01:26 PM - Followers: 189 - Board type: Free - Posts Today: 18

Cannabix Technologies Inc.

(formerly West Point Resources Inc.)

Frankfurt: 8CT:FRA)

And is a Vancouver, B.C. based  company

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.

Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida



Rights for 10 Years after 1st Product sold

What is FAIMS-MS?

It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost

Cannabix Technologies' Inc. common shares trade on
the Canadian Securities Exchange
and US OTC Pinksheets and European Frankfurt Exchange.

US Patent Application

Canada Patent Application

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing

CSE:BLO          Pinksheets: BLOZF  Frankfurt: 8CT:FRA

Common Shares
Issued and Outstanding 

 (as of Novermber 30, 2016)
Warrants Issued but not Exerscised  6,663,158
Options Issued but not Exercised  6,661,000
IF a Patent is Issued another 5M Shares

Fully Diluted w/Warrants, w/Options  and w/Patent issued 103,438,101

Cannabix Corporate Video

Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
BLOZF News: Cannabix Technologies Applauds Canadian Task Force Report on Cannabis Legalization and its Focus on Marijuana Impaired Driving 12/14/2016 09:00:00 AM
BLOZF News: Cannabix Technologies Releases Images of Beta 2.0 Cannabix Marijuana Breathalyzer 11/14/2016 08:00:00 AM
BLOZF News: Cannabix Technologies Develops Beta 2.0 Marijuana Breathalyzer 10/19/2016 08:45:00 AM
BLOZF News: Cannabix Technologies is Well-Positioned to Capitalize on Anticipated Marijuana Legalization in Canada and United States 10/04/2016 09:04:58 AM
BLOZF News: Justin Timberlake’s Aftermaster, Inc. (OTCQB: AFTM) Begins Production - Partners with ON Semiconductor (NADAQ: ON) 10/04/2016 07:00:00 AM
#16261  Sticky Note PITTCON CONFERENCE & EXPO 2017 McCormick Place Chicago, shell3 01/13/17 09:58:11 PM
#15195  Sticky Note Cannabix Technologies Releases Images of Beta 2.0 Cannabix FreezeThese 11/11/16 09:43:17 PM
#16321   LMFAO!!!!!!! euroconversions 01/16/17 02:18:02 PM
#16320   i wasnt there but ill fact check what hoyowasobo 01/16/17 02:01:26 PM
#16319   Yo Shell3! Have You Heard Anything Back Yet? LOL AMG 01/16/17 01:27:38 PM
#16318   hoyo, were you following that Release Period or shell3 01/16/17 12:44:13 PM
#16315   No will get no direct "conversation" or AMG 01/16/17 12:06:49 PM
#16314   THIS AMG post# 16309 SO75 01/16/17 11:58:09 AM
#16313   ... lets just wait and see how things hoyowasobo 01/16/17 11:57:20 AM
#16312   That's An Astounding Answer! This is 2017! Not AMG 01/16/17 11:43:33 AM
#16311   there is no contradiction imo. it seems like hoyowasobo 01/16/17 11:26:45 AM
#16309   A BLOZF Q & A Session AMG 01/16/17 11:04:37 AM
#16308   After hours maybe iluv blozf 01/16/17 09:41:00 AM
#16307   Guess no new$ today.( Carthnel 01/16/17 09:39:42 AM
#16306   and as a member of the board i hoyowasobo 01/16/17 07:19:20 AM
#16305   BTH has a laboratory tested, multi-million dollar government medchem 01/16/17 06:57:16 AM
#16304   I Have A Dream. You Should Too. Happy AMG 01/16/17 12:09:21 AM
#16303   Correction: 8800% return! Facts matter. AMG 01/15/17 06:18:53 PM
#16302   True. I even threw one out there not AMG 01/15/17 05:33:57 PM
#16301   As a Canadian, it will be US dollars iluv blozf 01/15/17 05:29:11 PM
#16300   My 2 Cent's - US Dollar shell3 01/15/17 05:13:45 PM
#16299   its not about the "valuable" tech its about hoyowasobo 01/15/17 04:57:20 PM
#16297   canadian dollars imo as its a canadian company hoyowasobo 01/15/17 04:43:47 PM
#16295   Na nose. I want some of that. geodcan 01/15/17 04:09:44 PM
#16294   Yes that's great, I was going to shell3 01/15/17 03:57:08 PM
#16292   You heard from an insider? Back when? But AMG 01/15/17 03:48:37 PM
#16291   Yes. Not necessarily. I have heard from an geodcan 01/15/17 03:39:46 PM
#16290   I will be at the conference in Chicago. JBowsNose 01/15/17 02:48:05 PM
#16289   P.S. Is a 2 to 3 dollar buyout AMG 01/15/17 11:19:54 AM
#16288   those who dont believe me should search medchem 01/15/17 09:39:28 AM
#16287   Hey goedcan - can you help me navigate AMG 01/15/17 09:14:55 AM
#16286   Always a holiday around the times we are StockRacer87 01/15/17 09:11:25 AM
#16285   Markets are closed that is a holiday to iluv blozf 01/15/17 09:08:59 AM
#16284   MLK is a Federal Holiday. Period. Therefore, USA AMG 01/15/17 12:20:23 AM
#16283   Its not a celebrated holiday in all the StockRacer87 01/14/17 11:26:55 PM
#16282   Right Back At You Buddy! Euro Conversions & AMG 01/14/17 10:47:29 PM
#16281   Shell3, AMG, lucky,mydog, Smoki, You guys rock. Thanks euroconversions 01/14/17 09:40:43 PM
#16280   Doubt there will be news before the 15th. iluv blozf 01/14/17 09:39:45 PM
#16279   DITO, AGREE. THANK YOU BOTH rjp15 01/14/17 06:52:52 PM
#16278   Thanks for that Info lucky, and thanks shell3 01/14/17 06:13:30 PM
#16277   call the company and ask geodcan... hoyowasobo 01/14/17 06:11:57 PM
#16276   it can trade but it is on the lucky,mydog 01/14/17 06:00:23 PM
#16275   euroconversions thanks for the Heads-up shell3 01/14/17 05:57:42 PM
#16274   Oh hoyo AMG 01/14/17 05:29:26 PM
#16273   Thanks Shell3, I'm sure I'll be learning lots DBLIVEGONZO 01/14/17 03:30:22 PM
#16271   Welcome to BLOZF Board DBLIVEGONZO shell3 01/14/17 03:17:40 PM
#16270   thanks for your opinion! i have to disagree hoyowasobo 01/14/17 03:11:47 PM
#16269   Thank you for correcting his points. Breathtec will medchem 01/14/17 02:58:27 PM
#16268   I'm staying long and I know the risks. geodcan 01/14/17 02:44:04 PM
#16267   DB...I for one, completely disagree with the following opinions: AMG 01/14/17 02:20:24 PM
#16266   Off topic but relative - Has anyone noticed a euroconversions 01/14/17 01:26:49 PM
#16265   yes it will be indeed. im invested heavily hoyowasobo 01/14/17 12:36:36 PM